Ascendis Pharma A/S vs Dover Corp — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Dover Corp trades at $208.79 (market cap $28.07B). The key difference: Dover Corp is the larger of the two by market cap, and Dover Corp pays a 1.01% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | DOV | |
|---|---|---|
Market Cap | $16.67B | $28.07B |
Sector | Health | Industrials |
52-Week High | $277.18 | $233.31 |
52-Week Low | $189.74 | $161.16 |
Enterprise Value | $17.04B | $29.58B |
Dividend Yield | — | 1.01% |
Trailing returns across standard periods
Latest headlines on both assets
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →